Orgenesis Inc. ( ORGS) - Key Metrics
ORGS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.01 | $0.19 | -$0.10 | -$0.10 |
| 2024Q2 | $0.01 | -$0.23 | -$0.15 | -$0.15 |
| 2024Q1 | $0 | -$0.29 | -$0.13 | -$0.14 |
| 2023Q4 | -$0.43 | -$1.09 | -$0.02 | -$0.02 |
| 2023Q3 | $0 | $0.43 | -$0.04 | -$0.05 |
ORGS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | 5.76 |
| 2024Q2 | ? | -7.09 |
| 2024Q1 | ? | -4.93 |
| 2023Q4 | ? | -1.15 |
| 2023Q3 | ? | 3.57 |
ORGS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q3 | -2.23% | ? |
| 2024Q2 | -2.34% | ? |
| 2024Q1 | -2.41% | ? |
| 2023Q4 | -0.35% | ? |
| 2023Q3 | -0.82% | ? |
ORGS
Price: $0.32
52 week price:
Earnings Per Share: -24.46 USD
P/E Ratio: -0.02
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23800
Market Capitalization: 2.6 million